Stockreport

Y-mAbs in-licenses novel antibody technology for use in cancer [Seeking Alpha]

Y-mAbs Therapeutics, Inc.  (YMAB) 
Last y-mabs therapeutics, inc. earnings: 11/13 04:01 pm Check Earnings Report
PDF Y-mAbs Therapeutics (YMAB-3.4%agreementThe SADA technology uses a targeted payload delivery method whereby antibody constructs assemble in large molecules called tetrame [Read more]